Background: There are well-documented disparities in lung cancer outcomes across
populations. Lung cancer screening (LCS) has the potential to reduce lung cancer mortality …

Lung cancer is the leading cause of cancer mortality in the United States. Certain groups are
at increased risk of developing lung cancer and experience greater morbidity and mortality …

Nonsmall cell lung cancer (NSCLC) is the leading cause of cancer deaths. Lung cancer
screening (LCS) reduces NSCLC mortality; however, a lack of diversity in LCS studies may …

Abstract Background/Purpose Lung cancer is the leading cause of cancer death in the
United States. Black Americans have the highest rate of lung cancer mortality, due to being …

Background Criteria for low-dose CT scan lung cancer screening vary across guidelines.
Knowledge of the eligible pool across demographic groups can enable policy and …

Importance Lung cancer incidence and mortality disproportionately affect women and
racial/ethnic minority populations, yet screening guidelines for the past several years were …

Lung cancer screening is just starting to be implemented across the United States.
Challenges to screening include access to care, awareness of the option for screening …

Lung cancer screening (LCS) with annual low radiation dose computed tomography (LDCT)
for adults aged 55 years to 80 years with a 30 pack-year history of smoking was initially …

Background To address disparities in lung cancer screening (LCS) that may exclude large
numbers of high-risk African American smokers, revised US Preventive Services Task Force …

Background Low adoption of lung cancer screening is potentially caused by inadequate
access to a comprehensive lung cancer screening registry (LCSR), currently a requirement …